The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
iwCLL 2019 | Treating and diagnosing CLL in India
Abraham Varghese
• 22 Sep 2019
Abraham Varghese, MBBS, PhD, Leeds Institute of Cancer, Leeds, UK, describes how the treatment of chronic lymphocytic leukemia (CLL) is changing in India. This interview took place at the 18th International Workshop on Chronic Lymphocytic Leukemia (iwCLL) Biennial Meeting, held in Edinburgh, UK.
